The observational Post-Market Clinical Follow-up activity with the dialysis catheters LT from Joline GmbH & Co.KG

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027404

Enrollment

575

Registered

2021-12-10

Start date

2021-03-11

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N17

Interventions

Group 1: Data collection of patients treated with the CE-marked long-term dialysis catheters from the Joline GmbH used within the current standards of care without any additional interventions.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - use of a CE-marked dialysis catheters LT from the Joline GmbH according to the described indications in the IFU - signed informed and data protection consent form

Exclusion criteria

Exclusion criteria: - Patients with any contraindication according to the IFU

Design outcomes

Primary

Measure	Time frame
The aim of the PMCF activity is to assess safety, performance, and benefit of the CE-marked long-term dialysis catheters used in clincial routine within their indication according to the IFU.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Germany

Contacts

Public ContactNatasa Mitrovic

LS medcap GmbH

natasa.mitrovic@lsmedcap.com0747198499545

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026